A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)
Clinical trial NCT04093024 · COMPLETED
Trial details
- NCT number
- NCT04093024
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2022-05-24
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.